BioCentury
ARTICLE | Company News

Spectrum Pharmaceuticals, Altair deal

June 12, 2006 7:00 AM UTC

The companies resolved their arbitration related to milestone payments under a 2005 deal in which SPPI received exclusive worldwide rights to develop and market ALTI's RenaZorb lanthanum-based phosph...